While TNF-α treatment did not drive increased hepatocyte steatosis in monoculture, both obese (p < 0.001) and proinflammatory (p = 0.04) medium formulations increased hepatocyte steatosis, in the A–L system with adipocytes as shown in Fig. 4. The gene discussed is TNF; the disease is steatosis.